T2	Exp 11 31	the interaction site
T3	Exp 35 69	the defective transcription factor
T4	Exp 73 118	the class II major histocompatibility complex
T5	Exp 148 168	the divergent X2-box
T6	Exp 171 173	We
T7	Exp 247 251	that
T8	Exp 272 283	the absence
T9	Exp 330 334	that
T10	Exp 335 345	the defect
T11	Exp 375 387	the activity
T12	Exp 349 363	this cell line
T13	Exp 513 517	that
T14	Exp 518 537	the affected factor
T15	Exp 600 633	the transcription initiation site
T16	Exp 711 736	the relevant cis-elements
T17	Exp 740 751	this system
T18	Exp 792 858	the DQB X-box (but not the DQB-W region or the DQB Y-box) upstream
T19	Exp 983 988	where
T20	Exp 989 1005	the entire X-box
T21	Exp 1015 1021	the X1
T22	Exp 1065 1086	the analogous regions
T23	Exp 1099 1113	The DQB X2-box
T24	Exp 1148 1181	the silent DRA reporter construct
T25	Exp 1208 1222	the DQB X2-box
T26	Exp 1228 1242	the DRA X2-box
T27	Exp 1263 1275	the activity
T28	Exp 1279 1295	the DQB promoter
T29	Exp 1299 1314	the mutant cell
T30	Exp 1370 1374	when
T31	Exp 1324 1334	the hybrid
T32	Exp 1477 1481	that
T33	Exp 1482 1502	the divergent X2-box
T34	Exp 1506 1515	the class
T35	Exp 1628 1643	the human class
T36	Exp 1455 1468	These studies
R2	Coref Anaphora:T7 Antecedent:T37
T1	Protein 1038 1045	HLA-DRA
T37	Exp 237 245	Clone-13
